BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$296.90
+$9.16(+3.18%)
60
Overall
75
Value
63
Tech
42
Quality
How is this score calculated?
Market Cap
$7.52B
Volume
454.70K
52W Range
$211.43 - $343.12
Target Price
$296.25

Company Overview

Mkt Cap$7.52BPrice$296.90
Volume454.70KChange+3.18%
P/E Ratio9.9Open$287.26
Revenue$2.6BPrev Close$287.74
Net Income$759.9M52W Range$211.43 - $343.12
Div YieldN/ATarget$296.25
Overall60Value75
Quality42Technical63

No chart data available

About Bio-Rad Laboratories Inc. Class A

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Biome Australia starts international multi-centre trial for first proprietary probiotic strain

Biome Australia Ltd ( ($AU:BIO) ) has shared an announcement. Biome Australia has launched a multi-centre, randomised, double-blind, placebo-contro...

TipRanks Australian Auto-Generated Newsdeskin 3 hours

Biome Australia to spotlight BMB18 clinical program and IP strategy in June investor webinar

TipRanks Australian Auto-Generated Newsdesk2 hours ago

Sobi’s Tryngolza cuts pancreatitis risk 85% in severe hypertriglyceridemia trial analysis

TipRanks Sweden Auto-Generated Newsdesk11 hours ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Haleon PLC Sponsored ADR (HLN)

Brian Anderson2 days ago

Jefferies Keeps Their Hold Rating on Bio-Rad Laboratories (BIO)

TipRanks Auto-Generated Intelligence Newsdesk5 days ago
ABCD
1SymbolPriceChangeVol
2BIO$296.90+3.2%454.70K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.